Patterns of treatment response in newly diagnosed epilepsy.

Neurology
M J BrodieP Kwan

Abstract

To delineate the temporal patterns of outcome and to determine the probability of seizure freedom with successive antiepileptic drug regimens in newly diagnosed epilepsy. Patients in whom epilepsy was diagnosed and the first antiepileptic drug prescribed between July 1, 1982, and April 1, 2006, were followed up until March 31, 2008. Outcomes were categorized into 4 patterns: (A) early and sustained seizure freedom; (B) delayed but sustained seizure freedom; (C) fluctuation between periods of seizure freedom and relapse; and (D) seizure freedom never attained. Probability of seizure freedom with successive drug regimens was compared. Seizure freedom was defined as no seizures for ≥1 year. A total of 1,098 patients were included (median age 32 years, range 9-93). At the last clinic visit, 749 (68%) patients were seizure-free, 678 (62%) on monotherapy. Outcome pattern A was observed in 408 (37%), pattern B in 246 (22%), pattern C in 172 (16%), and pattern D in 272 (25%) patients. There was a higher probability of seizure freedom in patients receiving 1 compared to 2 drug regimens, and 2 compared to 3 regimens (p < 0.001). The difference was greater among patients with symptomatic or cryptogenic than with idiopathic epilepsy. Less ...Continue Reading

References

Feb 5, 2000·The New England Journal of Medicine·P Kwan, M J Brodie
Apr 24, 2002·Neurology·Martin J Brodie, Patrick Kwan
Jan 13, 2006·Brain : a Journal of Neurology·Matti Sillanpää, Dieter Schmidt
Apr 19, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R Mohanraj, M J Brodie
Oct 17, 2006·Drugs·Patrick Kwan, Martin J Brodie
Jan 27, 2007·Annals of Neurology·Anna L Luciano, Simon D Shorvon
Sep 21, 2007·Annals of Neurology·Brian C CallaghanJacqueline A French
Jan 2, 2008·Neurology·Yitzhak Schiller, Yussef Najjar
Jul 11, 2008·The New England Journal of Medicine·Jacqueline A French, Timothy A Pedley
May 29, 2009·Annals of Neurology·Anne T BergRamona D'Souza
Oct 27, 2009·Neurologic Clinics·Linda J Stephen, Martin J Brodie
Nov 17, 2009·Lancet Neurology·Patrick Kwan, Martin J Brodie
Jan 29, 2011·Epilepsia·Brian CallaghanJacqueline French
Sep 7, 2011·Neurology·Anthony K NgugiC R Newton

❮ Previous
Next ❯

Citations

Sep 21, 2013·Nature Reviews. Drug Discovery·Wolfgang LöscherDieter Schmidt
Sep 12, 2012·Nature Reviews. Neurology·Samuel Wiebe, Nathalie Jette
Sep 29, 2012·Epilepsia·Martin J BrodieDieter Schmidt
Oct 31, 2012·Epilepsia·Martin J BrodiePatrick Kwan
Jun 7, 2013·Continuum : Lifelong Learning in Neurology·Jacqueline A French, Deana M Gazzola
Aug 2, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sarah L DeVosTimothy M Miller
May 24, 2013·Drug Design, Development and Therapy·Marco Mula
Dec 10, 2013·Imaging in Medicine·Negar MemarianRichard J Staba
Feb 14, 2014·Advances in Therapy·Joanna H CoxAndrea E Cavanna
Jan 15, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Dieter SchmidtMarc A Dichter
Feb 26, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Yvonne G WeberHolger Lerche
Mar 19, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Kang Min ParkSung Eun Kim
Sep 18, 2014·Clinical Neuropharmacology·Dong Wook KimJeeyoung Oh
Jul 16, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Stefan Rampp
Oct 6, 2012·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Arne ReimersEylert Brodtkorb
Sep 4, 2015·Expert Review of Neurotherapeutics·Valentina Franco, Emilio Perucca
Nov 19, 2013·Expert Review of Neurotherapeutics·Ana C Coan, Fernando Cendes
Jan 14, 2016·Expert Opinion on Pharmacotherapy·Pavel KleinIvan Rektor
Jun 7, 2013·Expert Review of Neurotherapeutics·Raimondo D'AmbrosioEmilio Perucca
Aug 22, 2014·Expert Review of Medical Devices·Felice T Sun, Martha J Morrell
Feb 28, 2016·Epilepsy Research·Daniel M Goldenholz, Shira R Goldenholz
Dec 3, 2015·Epilepsy & Behavior : E&B·David J ThurmanMatthew M Zack
Jan 6, 2016·Epilepsy & Behavior : E&B·Giorgia GiussaniUNKNOWN EPIRES Group
Feb 28, 2016·Seizure : the Journal of the British Epilepsy Association·Chunhong ShenMeiping Ding
Aug 30, 2014·Epilepsy & Behavior : E&B·R PourdeyhimiG U Martz
Nov 28, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Valentina FrancoEmilio Perucca
Feb 24, 2016·Journal of Veterinary Internal Medicine·M PodellS R Platt
Jul 31, 2013·Neurologic Clinics·Jorge J Asconapé
Dec 25, 2015·Epilepsy & Behavior : E&B·Martin J Brodie, Linda J Stephen
Dec 5, 2013·Epilepsia·Dong Wook KimUNKNOWN Korean Epilepsy Society
Jun 12, 2012·Lancet Neurology·Bassel W Abou-Khalil
Sep 13, 2015·Seizure : the Journal of the British Epilepsy Association·Wendy Waldman ZadehUNKNOWN SP0954 Study Group
Mar 5, 2016·Neurologia Medico-chirurgica·Ryosuke Hanaya, Kazunori Arita
Oct 3, 2014·Acta Neurologica Scandinavica·O M GonenM Y Neufeld

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved